Ivy Natal
Unlocking human fertility
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2C
- Website
- ivynatal.com
- Total Funding
- $250K
- Last Round
- $250K SeedApr 2020
About
Ivy Natal is a San Francisco-based VC-backed biotech company developing in vitro gametogenesis (IVG) technology to enable women who cannot produce eggs — due to surgery, chemotherapy, age, or genetic conditions — to have genetic children. The process begins with a simple skin biopsy and directly reprograms skin cells into healthy egg cells, bypassing traditional IVF limitations. Long term, the platform aims to extend reproductive choice to same-sex couples and anyone facing infertility.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account